𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study

✍ Scribed by T. Witthoeft; D. Hueppe; C. John; J. Goelz; R. Heyne; B. Moeller; G. Teuber; S. Wollschlaeger; A. Baumgarten; K.-G. Simon; G. Moog; N. Dikopoulos; S. Mauss


Book ID
108886404
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
153 KB
Volume
17
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy and safety of peginterferon alf
✍ Savino Bruno; Mitchell L. Shiffman; Stuart K. Roberts; Edward J. Gane; Diethelm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 500 KB πŸ‘ 1 views

The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40 KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis

Treatment of insulin resistance with met
✍ Manuel Romero-GΓ³mez; MoisΓ©s Diago; RaΓΊl J. Andrade; JosΓ© L. Calleja; Javier Salm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 1 views

Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12

Interferon alfa-2b in combination with r
✍ Regino P. GonzΓ‘lez-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 215 KB πŸ‘ 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh